InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by Mack David J.. Officer active across 1 company, notably BioXcel Therapeutics, Inc.. Aggregated, 13 reports have been published. Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
MACK DAVID J. is a Director of BioXcel Therapeutics, Inc. He has 13 filings in total, and the 13 sampled filings cover the period from 2024-12-03 to 2025-11-03. The most common transaction nature is Levée d'options, and the aggregate buy and sell amounts for the sampled filings are both EUR 0.